# Richard Lafayette

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/richard-lafayette/

## Facts

| Field | Value |
| --- | --- |
| Citations | 10,416 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 51 |
| i10-index | 120 |
| Last Known Institution | Stanford Medicine |
| OpenAlex ID | https://openalex.org/A5067563722 |
| ORCID iD | 0000-0003-3906-7934 |
| Works | 305 |

## Researcher papers

Showing 12 of 13.

- [Renal Physiology of Pregnancy](https://scholariq.org/papers/renal-physiology-of-pregnancy/)
- [Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy](https://scholariq.org/papers/rituximab-or-cyclosporine-in-the-treatment-of-membranous-nephropathy/)
- [Anaritide in Acute Tubular Necrosis](https://scholariq.org/papers/anaritide-in-acute-tubular-necrosis/)
- [Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass.](https://scholariq.org/papers/angiotensin-ii-receptor-blockade-limits-glomerular-injury-in-rats-with-reduced/)
- [A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis](https://scholariq.org/papers/a-randomized-controlled-double-blind-study-comparing-the-efficacy-and-safety-of/)
- [Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial](https://scholariq.org/papers/efficacy-and-safety-of-a-targeted-release-formulation-of-budesonide-in-patients/)
- [Podocytopenia and disease severity in IgA nephropathy](https://scholariq.org/papers/podocytopenia-and-disease-severity-in-iga-nephropathy/)
- [A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction](https://scholariq.org/papers/a-randomized-controlled-trial-of-rituximab-in-iga-nephropathy-with-proteinuria/)
- [Renal artery stenosis in kidney transplants](https://scholariq.org/papers/renal-artery-stenosis-in-kidney-transplants/)
- [Pathophysiology of the Clinical Manifestations of Preeclampsia](https://scholariq.org/papers/pathophysiology-of-the-clinical-manifestations-of-preeclampsia/)
- [Immunoglobulin A Nephropathy: Advances in Understanding of Pathogenesis and Treatment](https://scholariq.org/papers/immunoglobulin-a-nephropathy-advances-in-understanding-of-pathogenesis-and/)
- [Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA](https://scholariq.org/papers/differences-in-initial-treatment-modality-for-end-stage-renal-disease-among/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)

## Researcher university

- [Stanford Medicine](https://scholariq.org/institutions/stanford-medicine/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.